Federico Zacchini
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Federico Zacchini has a total of 3 co-authors. Here are the top co-authors by number of shared publications:
- Giulia Venturi
Department of Medical and Surgical Sciences (DIMEC), Bologna University, Via Massarenti 9, 40138, Bologna, Italy
1 shared publication - Lucio Montanaro
Department of Medical and Surgical Sciences (DIMEC), Bologna University, Via Massarenti 9, 40138, Bologna, Italy
1 shared publication - Valerio Gelfo
Department of Medical and Surgical Sciences (DIMEC), University of Bologna, 40138 Bologna, Italy
1 shared publication
Latest Publications
- Open Access
- 11 January 2024
- Published by MDPI AG in Biomedicines
- Vol. 12 (1) , 155
Decoding Ribosome Heterogeneity: A New Horizon in Cancer Therapy
The traditional perception of ribosomes as uniform molecular machines has been revolutionized by recent discoveries, revealing a complex landscape of ribosomal heterogeneity. Opposing the conventional belief in interchangeable ribosomal entities, emerging studies underscore the existence of specialized ribosomes, each possessing unique compositions and functions. Factors such as cellular and tissue specificity, developmental and physiological states, and external stimuli, including circadian rhythms, significantly influence ribosome compositions. For instance, muscle cells and neurons are characterized by distinct ribosomal protein sets and dynamic behaviors, respectively. Furthermore, alternative forms of ribosomal RNA (rRNAs) and their post-transcriptional modifications add another dimension to this heterogeneity. These variations, orchestrated by spatial, temporal, and conditional factors, enable the manifestation of a broad spectrum of specialized ribosomes, each tailored for potentially distinct functions. Such specialization not only impacts mRNA translation and gene expression but also holds significant implications for broader biological contexts, notably in the realm of cancer research. As the understanding of ribosomal diversity deepens, it also paves the way for exploring novel avenues in cellular function and offers a fresh perspective on the molecular intricacies of translation.
- 11 January 2024
- Published by MDPI AG in Biomedicines
- Vol. 12 (1) , 155
Open AccessDecoding Ribosome Heterogeneity: A New Horizon in Cancer Therapy
The traditional perception of ribosomes as uniform molecular machines has been revolutionized by recent discoveries, revealing a complex landscape of ribosomal heterogeneity. Opposing the conventional belief in interchangeable ribosomal entities, emerging studies underscore the existence of specialized ribosomes, each possessing unique compositions and functions. Factors such as cellular and tissue specificity, developmental and physiological states, and external stimuli, including circadian rhythms, significantly influence ribosome compositions. For instance, muscle cells and neurons are characterized by distinct ribosomal protein sets and dynamic behaviors, respectively. Furthermore, alternative forms of ribosomal RNA (rRNAs) and their post-transcriptional modifications add another dimension to this heterogeneity. These variations, orchestrated by spatial, temporal, and conditional factors, enable the manifestation of a broad spectrum of specialized ribosomes, each tailored for potentially distinct functions. Such specialization not only impacts mRNA translation and gene expression but also holds significant implications for broader biological contexts, notably in the realm of cancer research. As the understanding of ribosomal diversity deepens, it also paves the way for exploring novel avenues in cellular function and offers a fresh perspective on the molecular intricacies of translation.